May 27, 2014

The May/June 2014 Skin & Itch Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of AmLactin Cerapeutic Restoring, Cetaphil RestoraDerm Skin Restoring, Olay Advanced Healing Intensive, Curél Intesive Healing, Nivea Extended Moisture, Aveeno 1% Hydrocortisone Anti-itch, Extra Strength Benadryl Itch Stopping and Corizone 10 Anti-itch Ultra Moisturing Creme Plus.

March 26, 2014

The March/April 2014 Allergy Relief Ingredient Guide breaks down the indication, ingredients, purpose and dosage of Children's Claritin Chewable, Children's Allegra Allergy meltable tablets, Children's Benadryl Allergy Liquid, Nasacort Allergy 24HR, Mucinex Allergy, Hyland's 4 Kids Complete Allergy and Similasan Kids Allergy Eye Relief.

February 13, 2014

Reckitt Benckiser has line extended its Mucinex franchise into the year-round allergy sector with Mucinex Allergy, Heather Allen, Reckitt Benckiser EVP category development, told analysts Wednesday.

July 29, 2013

Reckitt Benckiser will be launching a product for nighttime cold and flu relief in both liquid and tablet form, the company's CEO told investors Monday morning.

June 17, 2013

Reckitt Benckiser, whose portfolio includes such brands as Clearasil, Mucinex and Lysol, is partnering with Save the Children to help drastically lower the global death rate of children younger than 5 years from diarrhea, a preventable illness, by 2020.

February 4, 2013

Perrigo chairman, CEO and president Joe Papa shared with analysts that private label OTCs are trending strong and that growth will be sustained going forward with the number of projected Rx-to-OTCs on the horizon.

November 8, 2012

Business for OTC store brands is expected to boom in the coming year, Perrigo chairman and CEO Joseph Papa told analysts discussing the private-label manufacturer's first quarter results during a conference call Wednesday, even as the growth rate across the entire OTC category slows.

April 12, 2012

Perrigo on Thursday announced that it has initiated shipments of its guaifenesin extended-release tablets in the 600-mg strength, a generic version of Mucinex.

November 28, 2011

Perrigo on Monday announced that it received final approval from the Food and Drug Administration for its store-brand version of Mucinex tablets.

August 17, 2011

Perrigo is planning to launch more than 45 new products in fiscal 2012 that will translate into approximately $190 million added to annual Perrigo sales, Perrigo chairman, president and CEO Joe Papa told analysts during the company's fourth-quarter conference call Tuesday.

July 14, 2011

Watson Pharmaceuticals last week confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex, Mucinex D and Mucinex DM extended-release products do not infringe Reckitt Benckiser’s U.S. Patent No. 6,372,252.

July 7, 2011

Reckitt Benckiser has launched a liquid formulation of its popular Mucinex brand to help fight coughs and colds in the coming season called Maximum Strength Mucinex Fast-Max Liquids. The four new formulations combine the mucus-busting power of Mucinex with maximum-strength medicines for multisymptom relief.

April 26, 2011

The American Pharmacists Association on Monday released its 2010 Pharmacy Today over-the-counter product survey and found that 92% of pharmacists walk a patient to the OTC section to assist with a product selection, noting that the average patient consult takes only three minutes of the patient's time.

February 10, 2011

Over-the-counter generic versions of a line of products used to treat congestion do not infringe on the patents covering the branded versions, a federal court ruled Wednesday.

January 3, 2011

Reckitt Benckiser on Monday supplemented its Mucinex and Delsym cough-cold portfolio with the addition of Cepacol from Combe.

August 23, 2009

Perrigo’s latest quarterly report underscores the relatively high expectations around cough-cold-flu this year because of...